In today’s ACT Brief, we explore how AI and tokenized data are improving patient-protocol matching, highlight Caplyta’s new ...

Novel trial designs like basket, umbrella, and platform trials enhance efficiency and reduce development timelines in precision medicine. Basket trials test a single therapy across different tumor ...

ACT: Recruitment strategies often struggle to scale across therapeutic areas and geographies. What approaches are helping overcome that challenge?

Understand how combining proprietary and real-world datasets with tokenization enables accurate protocol matching while ...

In contrast, by utilizing technology-driven tools more effectively, we can drive efficiencies, improve communication, and ...

In today’s ACT Brief, we explore how real-world data can improve protocol design and feasibility, highlight new findings from ...

Eli Lilly has shared positive results from a Phase II clinical trial (NCT06230523) evaluating eloralintide, an investigational once-weekly, selective amylin receptor, in adults with obesity or ...

Gain insight into how principal investigator scarcity, frequent protocol amendments, and uneven site performance undermine ...

Learn how incorporating real-world data at study design can improve feasibility, reduce amendments, and align eligibility ...

Now, with the MATTERHORN data, we’ve seen that when we start with Imfinzi—or an IO—in a perioperative setting, which ...

In today’s ACT Brief, we highlight new insights on recruitment bottlenecks from Citeline’s Matt Holms, UCB’s first-in-class ...

Because the data [are] contextualized, we know who the physicians are [that are] working with the patients we aspire to treat ...